10. In regulation 2(1) (Interpretation) of the Food Supplements Regulations (Northern Ireland) 2003(1) in the definition of —
(a)“Directive 2001/83” for “Directive 2009/53/EC of the European Parliament and of the Council amending Directive 2001/82/EC and Directive 2001/83/EC, as regards variations to the terms of marketing authorisations for medicinal products;” substitute “Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC;”(2);
(b)“Directive 2002/46” substitute ““Directive 2002/46” means, subject to regulation 2(4), Directive 2002/46/EC of the European Parliament and of the Council on the approximation of the laws of the Member States relating to food supplements as last amended by Commission Regulation (EU) 2017/1203”(3); and
(c)“Regulation (EU) 1169/2011” after “No. 608/2004” insert “as last amended by Regulation (EU) 2015/2283 of the European Parliament and of the Council”.
S.R. 2003 No. 273, as last amended by S.R. 2014 No. 223
OJ No. L 117, 5.5.2017, p. 1
OJ No. L 173, 6.7.2017, p. 9